| Date Initiated by Firm | May 28, 2004 |
| Date Posted | July 28, 2004 |
| Recall Status1 |
Terminated 3 on September 10, 2004 |
| Recall Number | Z-1229-04 |
| Recall Event ID |
29289 |
| 510(K)Number | K874485 |
| Product Classification |
Enzyme Immunoassay, Opiates - Product Code DJG
|
| Product | TDx/TDxFLx Opiates Reagent, Product list number: 9673-60 |
| Code Information |
Lot/Unit numbers Exp. date 10750Q100 9/22/04 09650Q100 9/15/04 |
| FEI Number |
2623532
|
Recalling Firm/ Manufacturer |
Abbott Health Products, Inc. Hwy 2 Km 58.0 Barceloneta PR 00617
|
| For Additional Information Contact | Nydia I. Cancel 787-846-8256 |
Manufacturer Reason for Recall | Abbott Diagnostics Division has found that the oxymorphone cross-reactivity information in the 'Specific Performance Characteristics' section of the TDx/TDxFLx Opiates Reagent package insert (commodity number 32-2087/R5) does not match the current product performance. |
FDA Determined Cause 2 | Other |
| Action | A Device Correction Letter dated 5/28/04 was mailed to all customers. The letter explained the reason for the recall and provided specific instructions.
|
| Quantity in Commerce | 941 kits |
| Distribution | Distribution was to hospitals/laboratories |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DJG
|